Summit Investment Advisors »

Allogene Therapeutics shares owned by Summit Investment Advisors

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Summit Investment Advisors from 13F filings

Historical chart of Summit Investment Advisors investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by Summit Investment Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $16k 13k 1.24
2025-06-30 $15k 13k 1.13
2025-03-31 $19k 13k 1.46
2024-12-31 $28k 13k 2.13
2024-09-30 $36k 13k 2.80
2024-06-30 $19k 8.1k 2.33
2024-03-31 $36k 8.1k 4.47
2023-12-31 $26k 8.1k 3.21
2023-09-30 $26k 8.1k 3.17
2023-06-30 $30k 6.0k 4.97
2023-03-31 $30k 6.0k 4.94
2022-12-31 $41k 6.0k 6.86
2022-09-30 $65k 6.0k 10.77
2022-06-30 $68k 6.0k 11.26
2022-03-31 $49k 5.3k 9.19
2021-12-31 $80k 5.3k 15.00
2021-09-30 $137k 5.3k 25.69
2021-06-30 $139k 5.3k 26.07
2021-03-31 $162k 4.6k 35.26
2020-12-31 $116k 4.6k 25.25
2020-09-30 $173k 4.6k 37.66
2020-06-30 $183k 4.3k 42.71
2020-03-31 $65k 3.4k 19.40
2019-12-31 $87k 3.4k 25.96
2019-09-30 $91k 3.4k 27.16
2019-06-30 $90k 3.4k 26.86
2019-03-31 $51k 1.8k 28.93
2018-12-31 $47k 1.8k 26.66